Cell-free replication of the hepatitis C virus subgenomic replicon.
about
Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutationsHuman VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5BMechanisms of Cellular Membrane Reorganization to Support Hepatitis C Virus ReplicationQuantitative Analysis of the Hepatitis C Virus Replication ComplexTwo-step affinity purification of the hepatitis C virus ribonucleoprotein complex.Specific Inhibition of Bovine Viral Diarrhea Virus ReplicaseDinucleotide Analogues as Novel Inhibitors of RNA-Dependent RNA Polymerase of Hepatitis C VirusMathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 CellsHepatitis C Virus (HCV) NS5B Nonnucleoside Inhibitors Specifically Block Single-Stranded Viral RNA Synthesis Catalyzed by HCV Replication Complexes In VitroParticipation of Rab5, an Early Endosome Protein, in Hepatitis C Virus RNA Replication MachineryPyrophosphorolytic Excision of Nonobligate Chain Terminators by Hepatitis C Virus NS5B PolymeraseVisualization of Double-Stranded RNA in Cells Supporting Hepatitis C Virus RNA ReplicationSignificance in Replication of the Terminal Nucleotides of the Flavivirus GenomeThe FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C VirusHepatitis C Virus NS5B Polymerase Exhibits Distinct Nucleotide Requirements for Initiation and ElongationCritical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication ComplexFormation and function of hepatitis C virus replication complexes require residues in the carboxy-terminal domain of NS4B proteinEndocytic Rab proteins are required for hepatitis C virus replication complex formationVAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes.miR-122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes.Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replicationFluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replicationPoly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseasesHepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways.Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNAConserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition.Staufen1 promotes HCV replication by inhibiting protein kinase R and transporting viral RNA to the site of translation and replication in the cells.Cellular and molecular biology of HCV infection and hepatitis.Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta albaRole of annexin A2 in the production of infectious hepatitis C virus particlesUnique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s).Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
P2860
Q21560973-8E1CEAB9-5363-4DA2-B46C-814F64101CECQ24338324-17A8544D-374B-4E9D-A0B6-C023451B10BEQ26746922-EE30682C-7250-44BD-911C-CA8CD69BE330Q27472670-FC6B3217-195F-462A-98F7-283BA2DA1A48Q27472974-99211765-EE5C-4340-8933-4551EC9CDCB8Q27477452-8C5D0476-44A9-45C8-AD3A-877425C04376Q27477688-A7392967-556E-4BED-B265-24A2C344454AQ27478039-E59956C0-765F-407B-9C23-BDB427C644AAQ27478063-06FE4197-A4B2-432A-99FF-0546E87C6013Q27480343-511DF711-8767-4EFB-9858-23B053D1B96CQ27480921-94B4ED1F-7FA7-4990-95CC-0CBCDF718DF8Q27485448-524B589F-15F9-4631-97A9-1186B2D11280Q27485661-F2EEA750-B437-4409-A35B-2E4F4E8F8685Q27486114-75F35F07-1C74-4EA2-B6A7-CF67DC2331ECQ27488267-1E4041D6-A94D-48FD-9B3D-1FCFA5569F5CQ27488788-06F4DDA8-3179-40AB-A883-E12BE5DAC7BEQ27489811-E1FC2D92-2ED6-4ABE-99EE-F02661CA6750Q27490939-9B526ACD-2775-4C86-9E02-38B7B53777CFQ30155273-E17A79BB-2F99-4D83-86BE-CA3F65C531F6Q33204253-A8317B39-CECA-459F-AC9E-B3E6426E34BCQ34126418-5B0883CD-7BF3-44F0-A16B-FC8F04235822Q34593688-9C11E291-FD21-4236-BB94-86B6BE495ED4Q34996437-ADC4F99A-9C56-4607-966F-A0F2CE70B125Q35048926-540BDBDF-8E24-4791-AA74-98CF76E934B7Q35077451-4830295A-5092-43FF-A157-6FD4DCB9839EQ35140492-D7A4AB23-246E-45FE-8508-CFA2A2B7F517Q35531664-A81777E0-ADD8-4314-B268-2AB74BA8D3EFQ35861153-3CBA5FD3-6BE6-4964-8878-6157F10D2539Q36299678-5599DF34-A333-48D9-9873-1C4B2666FD0BQ36397362-09B2ABE0-8EE7-421E-9526-22DD253C9BC9Q36910780-19F69F6B-33A6-4E04-89B7-315A18CF0A9CQ36942703-2782266D-0C26-4938-9208-F0E83F26BAB1Q37021569-9B0C2FF7-CF36-4FB7-BB06-E8D9F343E535Q37514366-5BB59C25-DDDC-4998-84C8-7CAB9AA31D42Q38738857-A728A68D-FF72-44F4-AD82-C5EF05ABC536Q39268320-513DD538-2747-4566-9233-4AB14836799EQ39723381-280E80A8-96F7-4DEF-80EC-F678AC180505Q39756099-563130F6-C1EC-4494-94CA-22EE12A1ED21Q39960454-1F5E9D30-F91C-4BAF-A1E2-3E03CA4BDA6BQ40170241-A7E51274-052A-432D-AAF3-FD9783A92405
P2860
Cell-free replication of the hepatitis C virus subgenomic replicon.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Cell-Free Replication of the Hepatitis C Virus Subgenomic Replicon
@nl
Cell-free replication of the hepatitis C virus subgenomic replicon.
@ast
Cell-free replication of the hepatitis C virus subgenomic replicon.
@en
type
label
Cell-Free Replication of the Hepatitis C Virus Subgenomic Replicon
@nl
Cell-free replication of the hepatitis C virus subgenomic replicon.
@ast
Cell-free replication of the hepatitis C virus subgenomic replicon.
@en
prefLabel
Cell-Free Replication of the Hepatitis C Virus Subgenomic Replicon
@nl
Cell-free replication of the hepatitis C virus subgenomic replicon.
@ast
Cell-free replication of the hepatitis C virus subgenomic replicon.
@en
P2093
P2860
P3181
P1433
P1476
Cell-free replication of the hepatitis C virus subgenomic replicon.
@en
P2093
Aleem Siddiqui
Keith D Tardif
Naushad Ali
P2860
P304
12001-12007
P3181
P356
10.1128/JVI.76.23.12001-12007.2002
P577
2002-12-01T00:00:00Z